Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Ubiome Gut EXPLORER
10% OFF

Update : discount is suspended
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

London TMAU meeting with Prof Liz Shephard
19th Oct 11am - 1pm
St Mary's Hospital
Praed St, Paddington
London W2 1NY
click to read more

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Sunday, December 18, 2011

Update on the MEBO/Menssana Alveolar Breath Test/Research Study


MEBO/Menssana breath test : would you like to test ?


WHERE WOULD YOU GO
TO BE TESTED?
Please participate in the poll
only if you intend to go
.
This poll is provided to help MEBO Research determine whether there is enough interest in the various locations being considered. We have tentatively selected these destinations, and if you are willing to travel to any of these destinations, please select the location of your choice.

Any recommendation on an inexpensive physical site (preferably at no cost or donated) in any of these cities would be greatly appreciated. If you will be testing in England or Australia, please send me an email telling me which city(s) you would be able to travel to for the test. MEBO and Menssana will also ask each participant/ research subject to answer survey questions to assist Dr. Phillips with his analysis. Once the design of the Requisition and Survey Form is finalized and ready to be published in this blog, more information will follow on how to set up your own personal test in this study.


MEBO Research and Menssana Research
are organizing an alveolar breath research study to explore biomarkers for body odor and halitosis. Please note that although the participants/research subjects will receive their test scores when available, the final interpretation of these scores will not be available until the one-year study has been concluded and Dr. Phillips has finished his analysis and paper. This program is in essence a research study and not a diagnostic test at this stage.

The use of three BCA 5.0 instruments were donated free of charge by Dr. Phillips for a period of one year, while MEBO works at obtaining as many samples as possible worldwide.
MEBO is currently working on the logistics of the administration of this test, which has been progressing as hoped. Since participants/research subjects need to be physically present to perform the test, they would need to go to locations where one of the three (3) BCA 5.0 instruments will be shipped to by MEBO. The use of three BCA 5.0 instruments were donated free of charge by Dr. Phillips for a period of one year, while MEBO works at obtaining as many samples as possible worldwide. This highly sensitive and accurate instrument will be calibrated to perform an analytical process designed and patented by Menssana Research. It will analyze systemic conditions involving 200 odorant compounds, as mentioned in previous posts on the project, MEBO-Menssana Alveolar Breath Test project.


This does not mean that each participant will have to wait one year to receive his or her results, but it does mean that the scientific interpretation of the results from Dr. Phillips will be given at the end of the one-year long study.
Under the monitoring and review of one or more Institutional Review Board (IRB), also known as an Independent Ethics Committee (IEC) or Ethical Review Board (ERB), MEBO Research will collect as many breath samples as funding permits from members of our international community who suffer from body odor and halitosis for a period of one year. These samples will then be shipped to Menssana, and after a year’s compilation of data is analyzed by Dr. Michael Phillips, M.D., he will write a scientific paper with his conclusions of the study, as he and his associates have done in the published studies noted below*, to name a few. This does not mean that each participant will have to wait one year to receive their results, but it does mean that the scientific interpretation of the results from Dr. Phillips will be given at the end of the one-year long study.


We at MEBO Research appreciate the very strong and supportive response we have received from our international community. Thank you.

María

For additional posts on this topic, please click here:
Alveolar Breath Test/Research Study.


*Menssana Research Publications
  1. The IADR/AADR/CADR 83rd General Session (March 9-12, 2005), Prediction of Oral Malodor with Volatile Markers in the Breath.
  2. Oral Diseases (2005); 11 (Suppl. 1): 32-34. Pilot study of a breath test for volatile organic compounds associated with oral malodor: evidence for the role of oxidative stress.
  3. European Respiratory Journal (2004); 24: Suppl. 48, 467s. Volatile markers of pulmonary tuberculosis in the breath.
  4. Workshop on TB and HIV Diagnostics in Adult and Pediatric Populations, sponsored by NIH and FDA, Silver Spring, MD (June 29, 2011)
  5. Journal of Breath Research (Jan.22, 2010)Effect of influenza vaccination on oxidative sgtress products in breath.
  6. Clinica Chimica International (CCA), the International Journal of clinical chemistry and Diagnostic Laboratory Medicine, CCA10989 (May 31, 2008)Detection of lung cancer using weighted digital analysis of breath biomarkers.
  7. Journal of Clinical Oncology 2005; 23(16S): 839 S. Floor presentation at 2005 ASCO Annual Meeting, Orlando, Florida, May 16, 2005, Prediction of Lung Cancer Using Volatile Biomarkers in Breath.
  8. IOPScience, (Mar. 2, 2010). The Institute of Physics (IOP) is a not-for-profit society that provides publications through which leading-edge scientific research is distributed worldwide. Volatile biomarkers in the breath of women with breast cancer.

halitosis research
María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
The MEBO Forum Please sign the MEBO Petition

body odor petition
MEBO Research

0 comments:

Post a Comment